LGBT Cancer Project

Renal Cell Cancer Clinical Trials

A listing of Renal Cell Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

A Phase 1 clinical study for patients using SGN-2FF

UPDATED

Daphne Alabama 36526

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Mobile Alabama 36607

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Mobile Alabama 36608

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Arizona

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

California

UPDATED

Beverly Hills California 90211

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Duarte California 91010-3000

A Phase 1 clinical study for patients using SGN-2FF

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Los Angeles California 90095

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Los Angeles California 90032

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Los Angeles California 90048

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Los Angeles California 90048

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Orange California 92868

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Panorama City California 91402

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

San Francisco California 94143

A clinical research study of CPI-444 and CPI-444 + atezolizumab

San Francisco California 94143

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Santa Monica California 90403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Santa Rosa California 95403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Stanford California 94305

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Colorado

Aurora Colorado 80045

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Aurora Colorado 80045

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Aurora Colorado 80045-0510

A Phase 1 clinical study for patients using SGN-2FF

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Aurora Colorado 080045

Patients are needed to participate in a clinical research study of IMMU-132

Connecticut

New Haven Connecticut 06510

A clinical research study of CPI-444 and CPI-444 + atezolizumab

New Haven Connecticut 06519

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of IMMU-132

Delaware

Newark Delaware 19713

Patients are needed to participate in a clinical research study of IMMU-132

District of Columbia

Washington District of Columbia 20057

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Florida

Orlando Florida 32806

Patients are needed to participate in a clinical research study of IMMU-132

Sarasota Florida 34232

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Tampa Florida 33612

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Tampa Florida 33612

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

UPDATED

Tampa Florida 33612

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer